Wilmington Healthcare appoints new director to lead cloud-based healthcare customer intelligence tool

Wilmington Healthcare, which provides data, insight and intelligence for pharmaceutical, life sciences and medtech companies, healthcare charities and other NHS suppliers, has appointed Paul Rowe as Solution Director for the company’s Investigator XD product.

With more than 25 years’ experience of sales, marketing and training roles within the pharmaceutical industry, Paul will be responsible for the continuous development of Wilmington Healthcare’s Investigator XD platform as he brings together the company’s unrivalled, unique healthcare data and insight solutions into one cloud-based intelligence tool.

Paul is promoted from the role of Head of Sales at Wilmington Healthcare which he has held for nearly three years. Prior to this Paul has successfully held roles at Daiichi Sankyo and Bayer.

Paul says: “This is an exciting time at Wilmington Healthcare as we integrate our unrivalled data sources and information into one healthcare intelligence tool. We know ‘who’s who’ in the new NHS landscape and what their priorities and focus are better than anyone. And through our powerful insights platform we are able to inspire clients to transform their engagement with NHS customers – at a System, Place and Neighbourhood level - while identifying competitor vulnerability.

“We’re offering the capability to access the most powerful 360 degree view of the System all the way through to the individual customer. By truly integrating System objectives and pressure points, medicines management influences, prescribing decisions and patient outcomes, we are enabling the industry to maximise their market access. This rich data source is complemented by detail of the influential stakeholders, key influencers and opinion leaders across the new landscape in addition to the critical data detailing community demographics and social deprivation to help Industry work with NHS customers to tackle health inequalities and improve population health across care pathways.”

Jonathan Carney, Director of Insights and Key Account Management at Wilmington Healthcare, says: “Seismic shifts in the way the NHS is organised is directly impacting the way it will work with the life science and medtech sectors. This demands a rethink by Industry of the traditional key account management model and NHS customer intelligence tools if they wish to successfully engage, through tailored conversations, in this new environment.

“We are delighted that Paul is leading the next phase of our customer intelligence offering as we work with innovation to ensure that clients have the insight and intelligence to transform their relationships with health and social care partners into credible collaborations.”

For more information about Wilmington Healthcare’s insight and intelligence offer, please visit:  https://wilmingtonhealthcare.com/what-we-do/healthcare-insight/